Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

VOLTAREN-XR Drug Profile

« Back to Dashboard

Which patents cover Voltaren-xr, and what substitute generic drugs are available?

Voltaren-xr is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in VOLTAREN-XR is diclofenac sodium. There are forty-seven drug master file entries for this compound. Eighty-one suppliers are listed for this compound. There are five tentative approvals for this compound. Additional details are available on the diclofenac sodium profile page.

Summary for Tradename: VOLTAREN-XR

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list8
Bulk Api Vendors: see list146
Clinical Trials: see list10
Patent Applications: see list21,441
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VOLTAREN-XR at DailyMed

Pharmacology for Tradename: VOLTAREN-XR

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis
VOLTAREN-XR
diclofenac sodium
TABLET, EXTENDED RELEASE;ORAL020254-001Mar 8, 1996DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc